# Oral Isotretinoin and Covid-19 Infection

> **NCT04663906** · — · UNKNOWN · sponsor: **University of Aberdeen** · enrollment: 300 (estimated)

## Conditions studied

- Isotretinoin Adverse Reaction
- Covid19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04663906
- **Lead sponsor:** University of Aberdeen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-15
- **Primary completion:** 2021-05-31
- **Final completion:** 2021-05-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2020-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04663906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04663906, "Oral Isotretinoin and Covid-19 Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04663906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*